A. Silver stained gel from a GST-bMRJ pull-down assay using the NP-40 soluble fraction from isolated photoreceptor rod outer segments attached to their inner segments (ROS); lanes are molecular weight markers (1) and the GST-bMRJ plus ROS extract (2). Controls are GST-beads plus ROS (3) and GST-bMRJ alone (4). The prominent band at ≈115 kDa specifically pulled down by GST-bMRJ was excised from the gel and identified by MALDI-TOF as including retinal guanylyl cyclase 1 (GC1, Gucy2e). B. The identification of GC1 was confirmed by western blotting GST-bMRJ (lane 1) using a rabbit antibody specific for GC1 and a monoclonal antibody to rhodopsin (Rho); controls were GST-bMRJ alone (lane 2), GST plus ROS (lane 3), and a sample of 100 μg of the ROS soluble fraction (lane 4). GC1 was readily identified, but Rho, the most abundant protein in RIS-ROS preparation, was not identified. C. GST pull down assay using recombinant GST-bMRJ and His-tagged GC1 (lane 1, His-GC1); controls are GST beads plus His-GC1 (lane 2), His-GC1 alone to mark the position of GC1 (lane 3), GST-bMRJ alone (lane 4) and GST alone (lane 5). D. Reciprocal GST pull down assay using recombinant GST-GC1 plus His-mMRJ (lane 1); controls are GST plus His-mMRJ (lane 2), His-mMRJ alone (lane 3), GST-GC1 alone (lane 4) and GST alone (lane 5). Western blots in both C and D are with an anti-His antibody. E. Semi-quantitative analysis of GST-MRJ pull-down of GC1494-844. GST-MRJ and cleaved GC1494-844 were expressed and purified (see materials and methods), and GC1494-844 at concentrations from 0.03 to 0.5 μM (lanes 5-9) was incubated with 1.0 μM of GST-bMRJ for 45 min in 1% Nonidet P-40 homogenization buffer. Protein complexes were captured using 60 μl of glutathione sepharose beads (see Methods), and after washing were resuspended in 1× SDS sample buffer and resolved on SDS-PAGE. GC1 was detected by western blotting with anti-mouse GC1 antibody. Controls included beads plus GC1 (lane 1), GST plus GC1 (lane 2), and GST-bMRJ only (lane 3). In addition, 0.06 μM (lane 4) and 0.75 μM GC1 (lane 10) was loaded as a control for estimating GC1 concentration in lanes 5-9. F. Co-IP of GC1 (GC1), IFT88 and HSC70 with antibodies directed against GC1 (lane 4), MRJ (lane 5), and 4 different IFT proteins (lanes 6-9); IP antibodies shown at top and Western blot antibodies shown on left. 150 μg of retinal extract (RE) was loaded as a positive control (lane 3). Controls are protein G beads plus RE but without primary antibody (lane 1) and antibody plus beads without RE (lane 2).